Signatur Biosciences
Smart PCR kits for the diagnosis of complex diseases using transcriptional signatures.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
* | £6.2m | Early VC | |
| Total Funding | 000k | ||
Related Content
Signatur Biosciences is a molecular diagnostics company that has developed a technology to expand the capabilities of PCR testing for a wider range of medical conditions. The company designs and produces smart PCR kits that can detect complex diseases by using transcriptional signatures, which are patterns of gene expression.
Their approach simplifies the diagnostic process for intricate diseases, making it as straightforward as a conventional COVID-19 test. The company's core technology is based on research from Imperial College London and it is backed by YCombinator. Signatur Biosciences operates in the healthcare sector, specifically in the field of molecular diagnostics, and its primary clients are likely to be clinical laboratories, hospitals, and research institutions. The business model revolves around the sale of these specialized PCR kits.
Keywords: molecular diagnostics, PCR testing, transcriptional signatures, gene expression, complex diseases, medical diagnostics, healthcare, biotechnology, life sciences, diagnostics